Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy

por Arnon, Tal I., Markel, Gal, Bar-Ilan, Ahuva, Hanna, Jacob, Fima, Eyal, Benchetrit, Fabrice, Galili, Ruth, Cerwenka, Adelheid, Benharroch, Daniel, Sion-Vardy, Netta, Porgador, Angel, Mandelboim, Ofer
Publicado 2008

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy

por Arnon, Tal I., Markel, Gal, Bar-Ilan, Ahuva, Hanna, Jacob, Fima, Eyal, Benchetrit, Fabrice, Galili, Ruth, Cerwenka, Adelheid, Benharroch, Daniel, Sion-Vardy, Netta, Porgador, Angel, Mandelboim, Ofer
Publicado 2008

Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy

por Arnon, Tal I., Markel, Gal, Bar-Ilan, Ahuva, Hanna, Jacob, Fima, Eyal, Benchetrit, Fabrice, Galili, Ruth, Cerwenka, Adelheid, Benharroch, Daniel, Sion-Vardy, Netta, Porgador, Angel, Mandelboim, Ofer
Publicado 2015

MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors

por Nass, Dvora, Rosenwald, Shai, Meiri, Eti, Gilad, Shlomit, Tabibian‐Keissar, Hilla, Schlosberg, Anat, Kuker, Hagit, Sion‐Vardy, Netta, Tobar, Ana, Kharenko, Oleg, Sitbon, Einat, Lithwick Yanai, Gila, Elyakim, Eran, Cholakh, Hila, Gibori, Hadas, Spector, Yael, Bentwich, Zvi, Barshack, Iris, Rosenfeld, Nitzan
Publicado 2008